ClinicalTrials.gg
Status unknownNCT04056936Updated Aug 19, 2019

The Scope of Tongue-tie in Norway: Its Prevalence and Consequences for Child Health

An observational study in Tongue Tie and Ankyloglossia, sponsored by University of Oslo. Status unknown. Open to participants aged 1 Day to 2 Weeks. Per ClinicalTrials.gov, last updated 2019-08-19.

Sponsored by University of Oslo · Observational

The sponsor has not verified this record recently (last verified Aug 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
1 Day to 2 Weeks
Sex
All
01

Study summary

The study is a prospective multi-centre clinical follow-up study of prevalence and severity of tongue-tie in neonates in Norway. During one year around 2600 newborn infants will be examined for tongue-tie in the two participating hospitals. The infants diagnosed with a tongue tie, will be followed to assess the proportion of infants treated and the severity. Feeding outcomes will be observed up to 6 months of age.

Read the detailed description

A tongue-tie may cause problems for child and mother. There are no previous studies from Norway that have assessed the magnitude and severity of tongue-tie in infants. The prevalence of tongue-tie in Norway and to what degree it influences mother and child health is unknown. It is of great importance to address a problem with possible negative effect on breastfeeding and maternal and child health. Current clinical practice varies due to incomplete knowledge of the condition. An unknown proportion of infants with tongue-tie may not be diagnosed or receive treatment. Current international research recommends treatment of tongue-tie if it causes breastfeeding problems. This project will add significant knowledge about tongue-tie in Norway.

The project supports:

  • Filling knowledge gaps by researching the prevalence and severity of the condition.
  • Obtaining new knowledge for the health services by establishing assessment of tongue-tie prevalence in Norway. This can be used for planning of the healthcare services.
  • Improving existing practice by describing the condition and implementing best practice diagnosis and treatment.
  • Creating societal benefits by improving infant nutrition and maternal health.

During the year of the study, the pediatricians at each hospital will assess the prevalence of tongue-tie in all newborn infants in their hospital. The examination will be part of the standard newborn examination which usually takes place during the 2nd day of life. A simple and short registration form will be filled out electronically, noting the type of tongue-tie and symptoms for each infant with the diagnosis. In addition, the diagnosis Ankyloglossia Q38.1 will be registered in the electronic journal system. The examination of the infant's mouth is completely safe and is already performed to asses if there is a cleft palate. The pediatrician will examine the area under the tongue in addition to the palate. All newborn infants will be examined to obtain a trustworthy prevalence. If a frenotomy is required and performed, this will be registered in the registration form and the procedure code for frenotomy EJC 20 will be registered in the electronic journal system. The breastfeeding self-efficacy tool (BSES-SF) is used for patient reported outcome measures.as well as WHO's breastfeeding indicators

To map the severity determining any possible consequences a tongue-tie may have for breastfeeding and infant nutrition the investigators will follow-up a cohort of tongue-tied infants to register if the feeding, growth, thriving and speech of the infant/child is affected by a tongue-tie.

02

Conditions studied

  • Tongue Tie
  • Ankyloglossia

Keywords

  • Breastfeeding
  • Lactational mastitis
  • Infant nutrition
  • Infant growth
  • Speech development
  • Frenotomy
03

In context

Ankyloglossia

32 studies on the registry are indexed under Ankyloglossia; 8 are open to participants now.

Browse Ankyloglossia studies →

Lead sponsor

University of Oslo is the lead sponsor of 177 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 2 Weeks
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Infants 0 days to 2 weeks old diagnosed with a tongue tie in the counties of Telemark and Vestfold during the study enrollment period September 2019 - August 2020.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subject must be born in a participating hospital during the study period.
  • Subjects that are recruited for follow-up must have a diagnose of tongue-tie as determined by the pediatrician in the hospital.
  • Infants with a tongue-tie that have been treated with a frenotomy and infants that have not received treatment.

Exclusion criteria

Exclusion Criteria:

  • Infants where the parents do not wish to participate in the study or where the parents do not to understand English or Norwegian.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Infants diagnosed with a tongue-tie and a frenotomy

    If a tongue-tie is present at the routine newborn examination, the infant can be included in the study. If the infant also has breastfeeding problems and there is a decreased tongue mobility and poor sucking ability, the pediatrician may find indication for frenotomy. If the frenotomy is performed before discharge the infant is included in this group. All Mother-infant dyads will get breastfeeding support.

    Procedure: Frenotomy

  • Infants diagnosed with a tongue-tie and no frenotomy

    The infants that are recruited to the tongue-tie cohort that do not receive treatment before discharge. The pediatrician evaluates that the tongue tie does not cause any functional problems and no treatment is performed before discharge. All Mother-infant dyads will get breastfeeding support.

  • All infants born in Telemark and Vestfold Counties

    All the infants born in the study period that will contribute to the prevalence study.

Interventions

  • ProcedureFrenotomy

    To map the severity determining any possible consequences a tongue-tie may have for breastfeeding and infant nutrition we will follow-up a cohort of tongue-tied infants to register if the feeding, growth, thriving and speech of the infant/child is affected by a tongue-tie.

    Also known as: Breastfeeding support

06

What researchers measure

Primary outcomes

  1. Prevalence of ankyloglossia in Norway

    The to assess the prevalence of tongue-tie in newborn infants in Norway.

    Time frame: September 2019 - August 2021

Secondary outcomes

  1. Proportion of infants treated with a frenotomy

    The number of infants treated on indication after the standardized diagnostic approach and the method of treatment have been introduced in the centers of intervention.

    Time frame: September 2019 - December 2021

  2. Variations in diagnosis of tongue tie and breastfeeding outcomes

    Number of infants with the diagnosis Q38.1 in the intervention counties compared to counties that are not a part of the study.

    Time frame: September 2019 - December 2021

  3. Severity of breastfeeding problems

    Breastfeeding problems and the duration of exclusive breastfeeding measured in months in the tongue tied infants that receive treatment compared to those who are not treated.

    Time frame: September 2019 - December 2021

  4. Adverse events

    Severity of adverse events related to the treatment of the infant as assessed by CTCAE v5.0.

    Time frame: September 2019 - December 2021

Other outcomes

  1. Long term followup - Breastfeeding duration and introduction of solids

    Duration of any breastfeeding in months and any problems with the introduction of solids is mapped 3 years after inclusion in the study.

    Time frame: September 2019 - August 2023

  2. Long term followup - Speech development

    Problems with child's speech development at the age of 3 years. Referral to treatment by Speech Language Pathologist.

    Time frame: September 2019 - August 2023

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04056936
Lead sponsor
University of Oslo
Collaborators
The Hospital of Vestfold, Oslo University Hospital, Sykehuset Telemark
Responsible party
Atle Klovning (MD. PhD. Associate Professor, University of Oslo) — Principal investigator
First posted
Aug 14, 2019
Start date
Sep 1, 2019 (estimated)
Primary completion
Aug 31, 2020 (estimated)
Completion
Aug 31, 2022 (estimated)
Last update
Aug 19, 2019

Study contacts

Rønnaug Solberg, MD, PhD
Contact
Ronnaug.Solberg@rr-research.no
+ 47-91843808
Solveig T Holmsen, MD, MPH
Contact
soholm@ous-hf.no
+47-95824029
Atle Klovning, MD. PhD
study director · University of Oslo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion